*************MORE FROM 1998**************
=====================================================================
(PR NEWSWIRE) DJ: Biomoda Conducting Blind-Study of Early Detection Lung C
DJ: Biomoda Conducting Blind-Study of Early Detection Lung Cancer Test Through
LungCheck of Scottsdale, Ariz.; Patented Technology Presents a Leading Hope for
Lung Cancer Cure
ALBUQUERQUE, N.M.--(BW HealthWire)--July 15, 1998--Advanced Optics
Electronics Inc. (OTC BB:ADOT) today announced significant developments
regarding Biomoda Inc., a biotechnology company in which Advanced Optics has
approximately 27% ownership.
Biomoda Inc. has contracted with LungCheck(R) Inc. of Scottsdale, Ariz. to
perform a 60-patient blind-study on Biomoda's proprietary lung cancer
diagnosis technology. LungCheck is a respected cytopathology lab chosen for
their familiarity with sputum technology.
Biomoda's patented lung cancer test is capable of detecting lung cancer up
to six years earlier than any other available test. LungCheck's blind study
of Biomoda's revolutionary technology should be completed by September.
The results of this blind study will be presented to recognized medical
journals and will provide the third-party verification necessary for
presentation to the national media.
Biomoda's technology also encompasses the treatment of lung cancer.
Biomoda's prominent research team has included world-leading
cytopathologists, Dr. Geno Saccomanno of St. Mary's Hospital and Medical
Center, Dr. Jim Mulshine of the National Cancer Institute and the late Dr.
John Frost of Johns Hopkins University.
Biomoda believes this technology is a leading hope for a cure for lung
cancer. FDA approval will not be necessary for the patented non-invasive
lung cancer test, but will be required for the patented treatment process.
Biomoda Inc. is currently in discussions with several major pharmaceutical
companies regarding this patented technology. It is anticipated that results
from this latest round of studies will provide Biomoda with the data
necessary to conclude major marketing and distribution agreements with
several major partners in the United States and abroad.
This press release contains forward-looking statements with respect to the
results of operations, expectations and business of the company that
involves risk and uncertainties. The company's actual future results could
materially differ from those discussed. Risks and uncertainties of the
company will be detailed from time to time in the company's periodic reports
to be filed with the Securities and Exchange Commission.
Advanced Optics Company Information
Advanced Optics Electronics Inc. (OTC Bulletin Board: ADOT news) is a
developer of patented electronic display technology, utilizing ADOT's
proprietary SLM (Spatial Light Modulator) light valve. This industry-leading
technology can be utilized in many diverse fields including the production
of "television quality" advertising billboards, medical testing equipment,
military displays, computer monitors and high definition video transmission.
Advanced Optics Electronics actively seeks partnerships with companies in
fields that could benefit from ADOT's patented technology. ADOT also owns in
excess of 27% of Biomoda Inc., an emerging biotechnology company
specializing in breakthrough cancer diagnostics and therapy. Advanced Optics
Electronics Inc. has retained first right of refusal to design, manufacture
and distribute the necessary scanning testing devices for the lung cancer
tests using Advanced Optics Electronics' proprietary display technology.
Contact Advanced Optics Electronics Inc. at 505/797-7878 or visit their Web
site at adot.org.
CONTACT: Advanced Optics Electronics Inc.
505/797-7878
adot.org
08:35 EDT JULY 15, 1998 |
